New Vendor for an Existing Medicine for IBS with Diarrhea
A diagnostic test development company, Prometheus Laboratories, Inc., acquired the exclusive right to distribute Lotronex® in the United States. The medicine was previously marketed by GlaxoSmithKline for diarrhea predominant IBS. The medicine was initially pulled out of the market due to safety issues. However, this medicine is now available through a restricted route to a selected number of patients with diarrhea predominant IBS. Reuters .